Sabra Health Care REIT, Inc. (SBRA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q3 '16: 265.5M Q4 '16: 260.5M Q1 '17: 260.6M Q2 '17: 251.1M Q3 '17: 301M Q4 '17: 408.3M Q1 '18: 511.7M Q2 '18: 613.3M Q3 '18: 653.3M Q4 '18: 623.4M Q1 '19: 594.1M Q2 '19: 647.1M Q3 '19: 645.2M Q4 '19: 661.7M Q1 '20: 674.3M Q2 '20: 608.9M Q3 '20: 602.3M Q4 '20: 598.6M Q1 '21: 601.6M Q2 '21: 600.6M Q3 '21: 585.9M Q4 '21: 569.5M Q1 '22: 580.3M Q2 '22: 583.3M Q3 '22: 595.5M Q4 '22: 624.8M Q1 '23: 623M Q2 '23: 628.2M Q3 '23: 649.1M Q4 '23: 647.5M Q1 '24: 652.9M Q2 '24: 667.9M Q3 '24: 684.3M Q4 '24: 703.2M Q1 '25: 720M Q2 '25: 733M Q3 '25: 745.1M Q4 '25: 774.6M Q1 '26: 812.8M Q2 '26: 859.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-150M 0 150M 300M 450M Q3 '15: 76.6M Q4 '15: 79.4M Q1 '16: 44.3M Q2 '16: 64.9M Q3 '16: 72.2M Q4 '16: 70.3M Q1 '17: 104.8M Q2 '17: 87.9M Q3 '17: 77.6M Q4 '17: 158.4M Q1 '18: 202M Q2 '18: 382.3M Q3 '18: 402.4M Q4 '19: 69M Q1 '20: 181.9M Q2 '20: 127.9M Q3 '20: 141M Q4 '20: 138.4M Q1 '21: 136.6M Q2 '21: -25.5M Q3 '21: -51.8M Q4 '21: -113.3M Q1 '22: -106.1M Q2 '22: 43.3M Q3 '22: -17M Q4 '22: -77.6M Q1 '23: -127.7M Q2 '23: -123.3M Q3 '23: -88.3M Q4 '23: 13.8M Q1 '24: 49.5M Q2 '24: 52.3M Q3 '24: 97.2M Q4 '24: 126.7M Q1 '25: 140.8M Q2 '25: 182.3M Q3 '25: 175.1M Q4 '25: 155.6M Q1 '26: 156.2M Q2 '26: 65.4M Q3 '16 Q4 '17 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 150M 300M 450M Q3 '16: 175.8M Q4 '16: 175.9M Q1 '17: 182.8M Q2 '17: 135.7M Q3 '17: 95.4M Q4 '17: 135.8M Q1 '18: 205.8M Q2 '18: 293.1M Q3 '18: 365.6M Q4 '18: 360.6M Q1 '19: 312.9M Q2 '19: 340.9M Q3 '19: 354.5M Q4 '19: 372.5M Q1 '20: 393.3M Q2 '20: 349.2M Q3 '20: 360.9M Q4 '20: 354.9M Q1 '21: 348.6M Q2 '21: 338.5M Q3 '21: 347.9M Q4 '21: 356.4M Q1 '22: 351M Q2 '22: 343.8M Q3 '22: 346.1M Q4 '22: 315.7M Q1 '23: 320.9M Q2 '23: 314.7M Q3 '23: 289.4M Q4 '23: 300.6M Q1 '24: 285.1M Q2 '24: 294.9M Q3 '24: 309.3M Q4 '24: 310.5M Q1 '25: 338M Q2 '25: 338.8M Q3 '25: 341.2M Q4 '25: 348.6M Q1 '26: 366.7M Q2 '26: 371.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 90M 180M 270M Q2 '13: 37.4M Q3 '13: 37.8M Q1 '14: 39M Q2 '14: 44.1M Q3 '14: 47.9M Q1 '15: 59.6M Q2 '15: 59.5M Q3 '15: 65.4M Q1 '16: 65.2M Q2 '16: 65.5M Q3 '16: 65.6M Q1 '17: 65.9M Q2 '17: 65.7M Q3 '17: 112.4M Q1 '18: 178.5M Q2 '18: 178.7M Q3 '18: 178.9M Q1 '19: 178.4M Q2 '19: 182.3M Q3 '19: 192M Q1 '20: 206M Q2 '20: 206.2M Q3 '20: 206.7M Q1 '21: 212.6M Q2 '21: 216.3M Q3 '21: 222.1M Q1 '22: 231.6M Q2 '22: 231.7M Q3 '22: 231M Q1 '23: 231.2M Q2 '23: 232.2M Q3 '23: 231.2M Q1 '24: 233.4M Q2 '24: 233.8M Q3 '24: 237M Q1 '25: 240.3M Q2 '25: 240.9M Q3 '25: 243.6M Q1 '26: 256M Q2 '26: 252.3M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 0.00 0.90 1.80 2.70 Q3 '15: 1.15 Q4 '15: 1.11 Q1 '16: 0.55 Q2 '16: 0.84 Q3 '16: 0.95 Q4 '16: 0.92 Q1 '17: 1.45 Q2 '17: 1.19 Q3 '17: 0.95 Q4 '17: 1.46 Q1 '18: 1.55 Q2 '18: 2.36 Q3 '18: 2.45 Q4 '19: 0.37 Q1 '20: 0.98 Q2 '20: 0.66 Q3 '20: 0.72 Q4 '20: 0.67 Q1 '21: 0.66 Q2 '21: -0.09 Q3 '21: -0.22 Q4 '21: -0.51 Q1 '22: -0.49 Q2 '22: 0.19 Q3 '22: -0.08 Q4 '22: -0.34 Q1 '23: -0.56 Q2 '23: -0.54 Q3 '23: -0.39 Q4 '23: 0.05 Q1 '24: 0.20 Q2 '24: 0.21 Q3 '24: 0.41 Q4 '24: 0.54 Q1 '25: 0.60 Q2 '25: 0.77 Q3 '25: 0.73 Q4 '25: 0.64 Q1 '26: 0.63 Q2 '26: 0.26 Q3 '16 Q4 '17 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.